Literature DB >> 29702491

Acute kidney injury to chronic kidney disease transition: insufficient cellular stress response.

Sarah A Strausser1, Daisuke Nakano2, Tomokazu Souma1.   

Abstract

PURPOSE OF REVIEW: Recent epidemiological and preclinical mechanistic studies provide strong evidence that acute kidney injury (AKI) and chronic kidney disease (CKD) form an interconnected syndrome. Injured kidneys undergo a coordinated reparative process with an engagement of multiple cell types after injury; however, maladaptation to the injury subjects kidneys to a vicious cycle of fibrogenesis and nephron loss. In this review, we will outline and discuss the pathogenesis of AKI-to-CKD transition with an emphasis on dysregulated 'cellular stress adaptation' as a potential therapeutic target. RECENT
FINDINGS: Recent studies identify the crucial role of injured tubular epithelial cells in the transition from AKI to CKD. Damaged tubular cells undergo reactivation of developmental and epithelial-mesenchymal transition signaling, metabolic alteration, and cell-cycle arrest, thereby driving inflammation and fibrogenesis. Recent work highlights that cellular stress-adaptive pathways against hypoxic and oxidative stress provide insufficient protection after severe AKI episode.
SUMMARY: Insufficient cellular stress adaptation may underpin the persistent activation of inflammatory and fibrogenic signaling in damaged kidneys. We propose that harnessing cellular stress-adaptive responses will be a promising therapeutic strategy to halt or even reverse the deleterious process of AKI-to-CKD transition.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29702491     DOI: 10.1097/MNH.0000000000000424

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  9 in total

Review 1.  Potential targeted therapy and diagnosis based on novel insight into growth factors, receptors, and downstream effectors in acute kidney injury and acute kidney injury-chronic kidney disease progression.

Authors:  Li Gao; Xiang Zhong; Juan Jin; Jun Li; Xiao-Ming Meng
Journal:  Signal Transduct Target Ther       Date:  2020-02-14

2.  Disruption of CUL3-mediated ubiquitination causes proximal tubule injury and kidney fibrosis.

Authors:  Turgay Saritas; Catherina A Cuevas; Mohammed Z Ferdaus; Christoph Kuppe; Rafael Kramann; Marcus J Moeller; Jürgen Floege; Jeffrey D Singer; James A McCormick
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

Review 3.  Current understanding of the administration of mesenchymal stem cells in acute kidney injury to chronic kidney disease transition: a review with a focus on preclinical models.

Authors:  Lingfei Zhao; Fei Han; Junni Wang; Jianghua Chen
Journal:  Stem Cell Res Ther       Date:  2019-12-16       Impact factor: 6.832

4.  Mitochondrial Dysfunction in Cardiorenal Syndrome 3: Renocardiac Effect of Vitamin C.

Authors:  Raquel Silva Neres-Santos; Carolina Victoria Cruz Junho; Karine Panico; Wellington Caio-Silva; Joana Claudio Pieretti; Juliana Almeida Tamashiro; Amedea Barozzi Seabra; César Augusto João Ribeiro; Marcela Sorelli Carneiro-Ramos
Journal:  Cells       Date:  2021-11-05       Impact factor: 6.600

5.  Pifithrin-α ameliorates glycerol induced rhabdomyolysis and acute kidney injury by reducing p53 activation.

Authors:  Chen Yuqiang; Zhang Lisha; Wen Jiejun; Xue Qin; Wang Niansong
Journal:  Ren Fail       Date:  2022-12       Impact factor: 2.606

Review 6.  Cellular senescence in ischemia/reperfusion injury.

Authors:  Chaojin Chen; Muxu Zheng; Hongbiao Hou; Sijian Fang; Liubing Chen; Jing Yang; Weifeng Yao; Qi Zhang; Ziqing Hei
Journal:  Cell Death Discov       Date:  2022-10-18

Review 7.  Pediatric Acute Kidney Injury to the Subsequent CKD Transition.

Authors:  Fang Wang; Jie Ding
Journal:  Kidney Dis (Basel)       Date:  2020-11-23

Review 8.  Potential targeted therapy and diagnosis based on novel insight into growth factors, receptors, and downstream effectors in acute kidney injury and acute kidney injury-chronic kidney disease progression.

Authors:  Li Gao; Xiang Zhong; Juan Jin; Jun Li; Xiao-Ming Meng
Journal:  Signal Transduct Target Ther       Date:  2020-02-14

9.  Knockdown of lncRNA MALAT1 ameliorates acute kidney injury by mediating the miR-204/APOL1 pathway.

Authors:  Hai-Yuan Lu; Guo-Yi Wang; Jin-Wen Zhao; Hai-Tao Jiang
Journal:  J Clin Lab Anal       Date:  2021-07-09       Impact factor: 2.352

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.